Skip to main content

Paired Ends: Albert Luderer, Tim Hall

Premium

BioNano Genomics has elected Albert Luderer to its board of directors. He is currently CEO and director of Integrated Diagnostics, a personalized diagnostics company. Previously, he was president and CEO of BioTrove, which was acquired by Life Technologies. He has also served as CEO of therapeutics company Light Sciences, president and chief operating officer of BioMérieux, and has held senior management positions at Dianon Systems, Boehringer Mannheim, and Corning. He holds a PhD from Rutgers University.



Oxford Gene Technologies
has appointed Tim Hall as finance director, beginning in 2012. Previously, he was director of strategic planning at Medeva, chief financial officer at Celltech Pharmaceuticals, and most recently, finance director of Lombard Medical Technologies. He holds a degree in business administration from the University of Bath and qualified as an accountant with Touche Ross.
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.